- Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company Eli Lilly
- Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion The New York Times
- Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs CNBC
- With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug MarketWatch
- Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet Reuters
from "news" - Google News https://ift.tt/JNARkcG
No comments:
Post a Comment